The U.S. Food and Drug Administration Tuesday approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer...

During the second half of the 20th century, cases of asbestos-related diseases were investigated and recognised for the damage they were doing to residents. Several safety measures were developed and taken...

Puerto Rico has the lowest incidence rate of new lung cancer compared with all other races and ethnic groups in the United States, according to a study published last week in the Centers for Disease Control...

The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on...